0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Current Directions in Radiopharmaceutical Research and Development (Paperback, Softcover reprint of the original 1st ed. 1996) Loot Price: R4,434
Discovery Miles 44 340
Current Directions in Radiopharmaceutical Research and Development (Paperback, Softcover reprint of the original 1st ed. 1996):...

Current Directions in Radiopharmaceutical Research and Development (Paperback, Softcover reprint of the original 1st ed. 1996)

Steven J. Mather

Series: Developments in Nuclear Medicine, 30

 (sign in to rate)
Loot Price R4,434 Discovery Miles 44 340 | Repayment Terms: R416 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Radiophannaceutical research has recently undergone a major change in direction. In past years it has been concerned mainly with the development of perfusion tracers, the biodistribution of which reflect the regional blood flow to areas of major organs such as the heart and brain. However, a major new direction of interest now lies in the development of receptor-binding radio-tracers which can be used to perform in-vivo characterisation of diseased tissues and it is likely that much of the future research in this field will follow this direction. The difficulties in developing such tracers are considerable. The researcher must first identify a promising target for radiopharmaceutical development. High specific activity radioactive molecules must be designed and synthesised which will both bind to the target receptor with high affinity, and also have the physicochemical characteristics which will allow them to reach the target site in sufficient quantity while at the same time showing minimal uptake in non-target tissues. Thus the knowledge base required for radiophannaceutical development has now expanded beyond the limits of radiopharmaceutical chemistry to include aspects of biochemistry, molecular biology and conventional drug design. The portfolio of basic knowledge required to support current radiopharmaceutical development is changing and scientists working in this arena need to be trained in this regard. At the same time, the very latest developments in the field need to be communicated to the scientific community in order to stimulate the advancement of this exciting new direction of research.

General

Imprint: Springer
Country of origin: Netherlands
Series: Developments in Nuclear Medicine, 30
Release date: September 2011
First published: 1996
Editors: Steven J. Mather
Dimensions: 240 x 160 x 14mm (L x W x T)
Format: Paperback
Pages: 240
Edition: Softcover reprint of the original 1st ed. 1996
ISBN-13: 978-9401072892
Categories: Books > Medicine > Other branches of medicine > Nuclear medicine
Books > Medicine > Other branches of medicine > Medical imaging > Radiology
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
Promotions
LSN: 9401072892
Barcode: 9789401072892

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners